Document Detail


Atrial fibrillation: maintenance of sinus rhythm versus rate control.
MedLine Citation:
PMID:  8607388     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Atrial fibrillation represents a common and challenging arrhythmia. A rational approach to management of the individual case depends on careful assessment of the temporal of the arrhythmia, any associated cardiovascular disease, and any particular features suggesting the advisability or risks of any particular treatment regimen. The nature of an arrhythmia and of individual patient factors change over time, requiring a flexible approach to long-term treatment that may be defined only after months or years. While new treatment options such as catheter ablation techniques and implantable atrial defibrillators are being tested, old therapies (e.g., low-dose amiodarone) are undergoing reappraisal. Increasing recognition of the dangers of antiarrhythmic therapy used to maintain sinus rhythm is focusing attention on nonpharmacologic methods. All patients with persistent atrial fibrillation merit serious consideration for direct current cardioversion before accepting that atrial fibrillation is permanent, and many patients may benefit from more than one attempt to restore and maintain sinus rhythm.
Authors:
S M Sopher; A J Camm
Related Documents :
16481928 - Induction of atrial fibrillation after the routine use of adenosine.
15767288 - Prognostic relevance of atrial fibrillation in patients with chronic heart failure on l...
11830718 - Anticoagulation for cardioversion of atrial fibrillation.
14739718 - Role of dofetilide in patients with atrial fibrillation. insights from the symptomatic ...
19446838 - Electrocardiographic characteristics in angiographically documented occlusion of the do...
20525228 - Effective cardiac resynchronization therapy for an adolescent patient with dilated card...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  The American journal of cardiology     Volume:  77     ISSN:  0002-9149     ISO Abbreviation:  Am. J. Cardiol.     Publication Date:  1996 Jan 
Date Detail:
Created Date:  1996-05-23     Completed Date:  1996-05-23     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0207277     Medline TA:  Am J Cardiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  24A-37A     Citation Subset:  AIM; IM    
Affiliation:
Department of Cardiological Sciences, St. George's Hospital and Medical School, London, United Kingdom.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic beta-Antagonists / therapeutic use
Anti-Arrhythmia Agents / therapeutic use
Arrhythmias, Cardiac / etiology
Atrial Fibrillation / complications,  physiopathology,  therapy*
Calcium Channel Blockers / therapeutic use
Catheter Ablation
Digoxin / therapeutic use
Electric Countershock
Flecainide / therapeutic use
Heart Failure / etiology
Heart Rate*
Heart Ventricles / physiopathology
Humans
Quinidine / therapeutic use
Sinoatrial Node / physiopathology*
Thromboembolism / etiology
Time Factors
Chemical
Reg. No./Substance:
0/Adrenergic beta-Antagonists; 0/Anti-Arrhythmia Agents; 0/Calcium Channel Blockers; 20830-75-5/Digoxin; 54143-55-4/Flecainide; 56-54-2/Quinidine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Electrophysiologic mechanisms of perpetuation of atrial fibrillation.
Next Document:  Drug therapy for prevention of atrial fibrillation.